Literature DB >> 22108437

Glycerolipid/free fatty acid cycle and islet β-cell function in health, obesity and diabetes.

Marc Prentki1, S R Murthy Madiraju.   

Abstract

Pancreatic β-cells secrete insulin in response to fluctuations in blood fuel concentrations, in particular glucose and fatty acids. However, chronic fuel surfeit can overwhelm the metabolic, signaling and secretory capacity of the β-cell leading to its dysfunction and death - often referred to as glucolipotoxicity. In β-cells and many other cells, glucose and lipid metabolic pathways converge into a glycerolipid/free fatty acid (GL/FFA) cycle, which is driven by the substrates, glycerol-3-phosphate and fatty acyl-CoA, derived from glucose and fatty acids, respectively. Although the overall operation of GL/FFA cycle, consisting of lipolysis and lipogenesis, is "futile" in terms of energy expenditure, this metabolic cycle likely plays an indispensable role for various β-cell functions, in particular insulin secretion and excess fuel detoxification. In this review, we discuss the significance of GL/FFA cycle in the β-cell, its regulation and role in generating essential metabolic signals that participate in the lipid amplification arm of glucose stimulated insulin secretion and in β-cell growth. We propose the novel concept that the lipolytic segment of GL/FFA cycle is instrumental in producing signals for insulin secretion, whereas, the lipogenic segment generates signals relevant for β-cell survival/death and growth/proliferation. Crown Copyright Â
© 2011. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108437     DOI: 10.1016/j.mce.2011.11.004

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  65 in total

Review 1.  Connecting pancreatic islet lipid metabolism with insulin secretion and the development of type 2 diabetes.

Authors:  Yumi Imai; Ryan S Cousins; Siming Liu; Brian M Phelps; Joseph A Promes
Journal:  Ann N Y Acad Sci       Date:  2019-04-02       Impact factor: 5.691

Review 2.  Lipid-associated metabolic signalling networks in pancreatic beta cell function.

Authors:  Marc Prentki; Barbara E Corkey; S R Murthy Madiraju
Journal:  Diabetologia       Date:  2019-08-19       Impact factor: 10.122

3.  Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice.

Authors:  Ja Young Kim-Muller; Shangang Zhao; Shekhar Srivastava; Yves Mugabo; Hye-Lim Noh; YoungJung R Kim; S R Murthy Madiraju; Anthony W Ferrante; Edward Y Skolnik; Marc Prentki; Domenico Accili
Journal:  Cell Metab       Date:  2014-09-25       Impact factor: 27.287

4.  Chinese medicine Jinlida (JLD) ameliorates high-fat-diet induced insulin resistance in rats by reducing lipid accumulation in skeletal muscle.

Authors:  Sha-Sha Zang; An Song; Yi-Xuan Liu; Chao Wang; Guang-Yao Song; Xiao-Ling Li; Ya-Jun Zhu; Xian Yu; Ling Li; Chen-Xi Liu; Jun-Cong Kang; Lu-Ping Ren
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  Identification of a mammalian glycerol-3-phosphate phosphatase: Role in metabolism and signaling in pancreatic β-cells and hepatocytes.

Authors:  Yves Mugabo; Shangang Zhao; Annegrit Seifried; Sari Gezzar; Anfal Al-Mass; Dongwei Zhang; Julien Lamontagne; Camille Attane; Pegah Poursharifi; José Iglesias; Erik Joly; Marie-Line Peyot; Antje Gohla; S R Murthy Madiraju; Marc Prentki
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-11       Impact factor: 11.205

6.  Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells.

Authors:  Mourad Ferdaoussi; Xiaoqing Dai; Mette V Jensen; Runsheng Wang; Brett S Peterson; Chao Huang; Olga Ilkayeva; Nancy Smith; Nathanael Miller; Catherine Hajmrle; Aliya F Spigelman; Robert C Wright; Gregory Plummer; Kunimasa Suzuki; James P Mackay; Martijn van de Bunt; Anna L Gloyn; Terence E Ryan; Lisa D Norquay; M Julia Brosnan; Jeff K Trimmer; Timothy P Rolph; Richard G Kibbey; Jocelyn E Manning Fox; William F Colmers; Orian S Shirihai; P Darrell Neufer; Edward T H Yeh; Christopher B Newgard; Patrick E MacDonald
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

7.  Protective role of the ELOVL2/docosahexaenoic acid axis in glucolipotoxicity-induced apoptosis in rodent beta cells and human islets.

Authors:  Lara Bellini; Mélanie Campana; Claude Rouch; Marta Chacinska; Marco Bugliani; Kelly Meneyrol; Isabelle Hainault; Véronique Lenoir; Jessica Denom; Julien Véret; Nadim Kassis; Bernard Thorens; Mark Ibberson; Piero Marchetti; Agnieszka Blachnio-Zabielska; Céline Cruciani-Guglielmacci; Carina Prip-Buus; Christophe Magnan; Hervé Le Stunff
Journal:  Diabetologia       Date:  2018-05-12       Impact factor: 10.122

8.  PPARβ/δ affects pancreatic β cell mass and insulin secretion in mice.

Authors:  José Iglesias; Sebastian Barg; David Vallois; Shawon Lahiri; Catherine Roger; Akadiri Yessoufou; Sylvain Pradevand; Angela McDonald; Claire Bonal; Frank Reimann; Fiona Gribble; Marie-Bernard Debril; Daniel Metzger; Pierre Chambon; Pedro Herrera; Guy A Rutter; Marc Prentki; Bernard Thorens; Walter Wahli
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

9.  Characterization of phospholipids in insulin secretory granules and mitochondria in pancreatic beta cells and their changes with glucose stimulation.

Authors:  Michael J MacDonald; Lacmbouh Ade; James M Ntambi; Israr-Ul H Ansari; Scott W Stoker
Journal:  J Biol Chem       Date:  2015-03-11       Impact factor: 5.157

10.  Duration of rapamycin treatment has differential effects on metabolism in mice.

Authors:  Yimin Fang; Reyhan Westbrook; Cristal Hill; Ravneet K Boparai; Oge Arum; Adam Spong; Feiya Wang; Martin A Javors; Jie Chen; Liou Y Sun; Andrzej Bartke
Journal:  Cell Metab       Date:  2013-03-05       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.